4//SEC Filing
Stoner Elizabeth 4
Accession 0001179110-18-010969
CIK 0001235010other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 4:47 PM ET
Size
8.5 KB
Accession
0001179110-18-010969
Insider Transaction Report
Form 4
Stoner Elizabeth
Director
Transactions
- Sale
Common Stock
2018-08-27$27.33/sh−4,152$113,474→ 29,639 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-08-27−6,000→ 5,750 totalExercise: $13.16From: 2015-06-12Exp: 2024-06-12→ Common Stock (6,000 underlying) - Exercise/Conversion
Common Stock
2018-08-27$13.16/sh+6,000$78,960→ 33,791 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $27.20 to $27.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
MOMENTA PHARMACEUTICALS INC
CIK 0001235010
Entity typeother
Related Parties
1- filerCIK 0001415739
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 4:47 PM ET
- Size
- 8.5 KB